They do not have to do with weight
Improvement in fibrosis 1 stage without worsening of NASH was achieved in 26% with 30 mg and in 27% with 44 mg, versus 7% with placebo (p = 0.009 and p = 0.008), and resolution of NASH without worsening of fibrosis in 23% with 30 mg, 26% with 44 mg, and 37% with 15 mg, versus 2% with placebo
Other conditions that can cause issues with fat absorption include Crohns disease, pancreatitis, liver disease, exocrine pancreatic insufficiency (EPI), or cancers of the pancreas, liver, or bile duct
Cognitive Support and Alzheimer's Prevention Emerging research highlights GLP-1s potential in supporting brain health
Some of the most consistent are edema and shortness of breath
Confirm the concentration